The Division of Pharmaceutics and Translational Therapeutics
The Division of Pharmaceutics and Translational Therapeutics (PTT) focuses on physical pharmacy, dosage form development and performance, and industrial/manufacturing pharmacy, as well as the pharmacokinetics and pharmacodynamics of drugs and biological molecules. Several of the faculty in the PTT division are focused on research in drug delivery and targeting, pharmacogenomics and individualized therapy.
• 15 Full time faculty
• Annual average of ~ 56 graduate students and ~ 4 postdoctoral research scholars/research associates
• PTT faculty also participate in the biosciences and human toxicology interdisciplinary doctoral degree programs
• Active MS (pharmaceutics) and PhD programs parallel the research within the division in these same areas with particular specialization in formulation and pre-formulation sciences, biopharmaceutics, pharmacokinetics, pharmacodynamics, pharmacogenomics, novel drug delivery systems, cancer vaccines, and tissue engineering.
• Faculty in the PTT division have a diverse and extensive range of funding sources that include but are not limited to the National Institutes for Health, the National Science Foundation, the Food and Drug Administration, the National Institute for Pharmaceutical Education and Technology, Medicine for Malaria Venture, Pharmaceutical Industry and Foundations such as the American Cancer Society and the PhRMA foundation amongst others.
• Doctoral students from the PTT division’s academic programs are typically placed in their first permanent positions immediately following the conferral of their degree. These jobs include positions in government, industry and academia.
• The PTT division has a robust and vibrant alumni/former faculty base, including several graduates who hold senior positions in the pharmaceutical industry. They continue to be actively engaged in the academic activities of the PTT division and generously contribute both their time and resources to the division. Alumni of the PTT division have created and supported graduate student fellowships that include, but are not limited to, the Terrance and Donna Dahl Pharmaceutics Fellowship, and the Guillory-Matheson-Flanagan-Wurster Graduate Student Fellowship.
• The PTT division has generous support from Professor Emeritus Keith Guillory for the J. Keith Guillory Pharmaceutics Student Fellowship Award.
• PTT faculty regularly publish high-quality manuscripts in well-regarded pharmacy and pharmaceutical sciences journals.
• PTT faculty participate in leadership roles in national scientific committees such as the American Association for Pharmaceutical Scientists (AAPS), U.S. Pharmacopeial Convention and the National Association for Boards of Pharmacy. Many PTT faculty participate on a long-term basis on NIH grant review panels.
• PTT faculty participate in pharmaceutical science journals as editors in chief, guest editors or as members of the editorial boards. For example, Lee Kirsch is currently Editor-in-Chief for AAPS PharmSciTech.
• The PTT division has a culturally diverse graduate student population. The PTT division has an enviable track record of recruiting graduate students that come with prestigious international fellowships. These include Royal Thai Fellows, Fulbright Fellows, Iraqi Fellows, Jordanian University of Science and Technology Fellows and Egypt Ministry of Higher Education Fellows.